Concepedia

Michael Kishko

MK

21

Publications

2K

Citations

17

H-Index

2004

Active since

Affiliations

Sanofi (United States)(Current)

Beth Israel Deaconess Medical Center

Harvard University

Sanofi (France)

AVEO Oncology (United States)

Michael Kishko is an author at Sanofi (United States) specializing in medicine, immunology, and virology.

Top concepts

Publications per year

2004–2023

21

Publications

21

Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity

Dan H. Barouch, Maria Grazia Pau, Jerome Custers et al. · The Journal of Immunology · 2004 · 384 citations · Full text

Neutralizing Antibodies to Adenovirus Serotype 5 Vaccine Vectors Are Directed Primarily against the Adenovirus Hexon Protein

Shawn M. Sumida, Diana M. Truitt, Angelique A. C. Lemckert et al. · The Journal of Immunology · 2005 · 363 citations · Full text

Neutralizing Antibodies and CD8 <sup>+</sup> T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine Vectors

Shawn M. Sumida, Diana M. Truitt, Michael Kishko et al. · Journal of Virology · 2004 · 172 citations · Full text

, , +23

A Human T-Cell Leukemia Virus Type 1 Regulatory Element Enhances the Immunogenicity of Human Immunodeficiency Virus Type 1 DNA Vaccines in Mice and Nonhuman Primates

Dan H. Barouch, Zhi-Yong Yang, Wing-Pui Kong et al. · Journal of Virology · 2005 · 164 citations · Full text

Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines

Shawn M. Sumida, Paul F. McKay, Diana M. Truitt et al. · Journal of Clinical Investigation · 2004 · 119 citations · Full text

Rows per page

1–5 of 21